Walbrook PR AQSE IPO – ProBiotix Health PLC
31 March 2022
Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the Aquis Stock Exchange (“AQSE”) IPO of ProBiotix Health plc (“ProBiotix”), the life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions. ProBiotix was established by AIM-listed OptiBiotix Health plc to develop next-generation microbiome solutions for a wide range of health conditions and to deliver commercially successful products supported by a strong scientific evidence base.
.jpg "Fusion Antibodies - Landscape (Trimmed)")
.png "MyHealthChecked PLC_Logo_2 Line_Colour_Red_RGB_AW (003)"){kind=logo}
